For Manuscript Submission, Check or Review Login please go to Submission Websites List.
For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.
Neuropsychological Correlates of Transcription Factor AP-2Beta, and Its Interaction with COMT and MAOA in Healthy FemalesSchabram I.a · Eggermann T.b · Siegel S.J.c · Gründer G.a · Zerres K.b · Vernaleken I.a
aDepartment of Psychiatry and Psychotherapy, Medical Faculty, RWTH Aachen University, and JARA-Translational Brain Medicine, and bInstitute of Human Genetics, RWTH Aachen University, Aachen, Germany; cDepartment of Psychiatry Translational Research Laboratory, University of Pennsylvania, Philadelphia, Pa., USA Corresponding Author
Department of Psychiatry, Psychotherapy, and Psychosomatics
RWTH Aachen University
Pauwelsstrasse 30, DE-52074 Aachen (Germany)
Background: The transcription factor AP-2β has been shown to impact clinical and neuropsychological properties. Apparently, it regulates the transcription of genes that code for molecules which are part of the catecholaminergic transmission system. This investigation focuses on possible effects of the transcription factor AP-2β intron 2 polymorphism on cognitive performance parameters. Methods: This hypothesis-driven investigation examined the effects and interactions of the transcription factor AP-2β intron 2 polymorphism, the Val158Met catechol-O-methyltransferase (COMT) polymorphism, and the variable number of tandem repeat polymorphism of monoamine oxidase A (MAOA) on cognitive performance parameters within a group of 200 healthy women (age: mean ± SD, 23.93 ± 3.33 years). Results: The AP-2β polymorphism significantly influenced cognitive performance (in particular, the Trail Making Test part B), whereas the MAOA and COMT polymorphisms did not. However, there was an interaction effect of the AP-2β × MAOA × COMT genotypes on the decision bias β of the degraded-stimulus version of the continuous performance task. Only the Val158Met COMT polymorphism showed an influence on personality questionnaires (openness and self-transcendence; NEO Five-Factor Inventory, Temperament and Character Inventory). Conclusion: The transcription factor AP-2β intron 2 polymorphism had more influence on cognition than the MAOA and COMT polymorphisms. Possibly, the AP-2β genotype might influence cognition through pathways other than those that regulate MAOA and COMT transcription. Interactions of transcription factor AP-2β, COMT, and MAOA polymorphisms suggest higher leverage effects of transcription factor AP-2β in subjects with high dopamine availability.
© 2013 S. Karger AG, Basel
Transcription factors are proteins that regulate genetic transcription by binding to the promoter regions of genes. In the brain, the transcription factor AP-2β is widely involved in the synthesis of proteins, some of which are a part of the catecholaminergic and serotonergic transmission system. Accordingly, the synthesis of receptors, transporters, and enzymes within the dopamine system are affected by AP-2β-mediated regulation. It has previously been reported that a polymorphic region of the AP-2β gene exists and that this region consists of a variable number of [CAAA] repeats in the second intron of the gene, which is located on chromosome 6p12-p21.1 . This sequence is repeated either 4 or 5 times [2,3].
Previous studies have suggested that this AP-2β polymorphism is involved in several clinical and neurobiological parameters [4,5,6]. The AP-2β polymorphism is also associated with binge eating disorder; frequencies of homozygotic carriers of the long allele (5/5 [CAAA]) are higher in patients suffering from binge eating . Furthermore, in healthy subjects, long-allele carriers exhibit lower scores on questionnaires that reflect anxiety-related personality traits and indirect aggression . Finally, lower platelet monoamine oxidase B activity is associated with homozygote long-allele carrier status. In rats, the AP-2β genotype has been shown to have an impact on dopamine and serotonin metabolism in the frontal cortex . Additionally, only females with 2 short alleles show decreased homovanillic acid (HVA) concentrations in the cerebrospinal fluid compared to carriers with at least 1 long allele . These results suggest a substantial relevance of AP-2β in dopaminergic turnover and transmission. Other studies have indicated that a high dopamine synthesis capacity is supportive to maximize cognitive performance most probably by enabling an optimal modulation of dopamine signaling [8,9]. Following this line of reasoning, the AP-2β intron 2 polymorphism might be involved in individual cognitive performances. To the best of our knowledge, there are no previous studies that have investigated the influence of AP-2β on cognitive performance. We hypothesize that subjects with the 4/4-repeat AP-2β genotype show better cognitive performance compared to 5/5 carriers because the above-mentioned  decreased HVA levels in 4/4 carriers are thought to depict a lower dopamine metabolism by monoamine oxidase (MAO) enzymes, the formation of which is under control of AP-2β. Under these premises, lower HVA levels might be a surrogate marker for higher capacities of dopamine transmission. The latter was consistently described to be associated with better cognitive performance [9,10,11].
Given the AP-2β intron 2 polymorphism would show a relevant effect on cognition via modulations of the dopamine metabolism, it might be hypothesized that other well-described polymorphisms that influence the pathways of dopamine degradation could exert additional effects. Some investigations were performed that focused on a polymorphism of the enzyme catechol-O-methyltransferase (COMT, Val158Met polymorphism; rs4680); COMT is an important enzyme of dopamine metabolism (for a review, see Barnett et al. ). Together with MAO, it is responsible for the degradation of dopamine into HVA. With respect to the COMT polymorphism, some authors reported that the Val alleles contribute to states of lower cognitive performance due to higher metabolism rates. Whereas some groups propose that the trimodal distribution of COMT activity results in such differences of cognition, other authors reported no effects [13,14,15]. A meta-analysis of Barnett et al.  found no or very little effect of COMT on cognitive performance.
The well-known variable number of tandem repeat (VNTR) MAOA polymorphism might theoretically also modulate the cognitive performance by different enzyme activities and different capacities of the dopamine transmission system. Whereas some studies focused on the behavioral impact of the VNTR MAOA polymorphism, no relevant investigation has been performed on cognition yet. Before the background of recent research results, strong effects of these COMT and MAOA polymorphisms could not be anticipated. However, it might be possible that lower enzyme activities of MAOA and COMT (e.g. COMT [Met/Met] and MAOA [3/3 VNTR]) could sum up to the postulated AP-2β effects (see before). Therefore, the proposed functional interplay between the AP-2β, COMT, and MAOA polymorphisms was investigated in a sample of 200 healthy female subjects. All subjects were genetically characterized and performed cognitive tasks which were previously shown to be sensitive to dopaminergic transmission.
This study was approved by the Ethics Committee of the Medical Faculty of RWTH Aachen University. All subjects were recruited by advertisements in public institutions. A total of 200 unrelated healthy females were included in the study after they had given written informed consent to participate. The mean age ± SD was 23.93 ± 3.33 years. After an initial screening of 306 subjects by telephone conversation, 206 subjects were invited to attend the initial examination/visit (study information, check for inclusion/exclusion criteria). The major exclusion criteria were mental disorders (according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, including nicotine dependence/abuse), somatic disorders, and the psychiatric treatment of first-degree relatives. The inclusion criteria consisted of Caucasian origin, right-handedness, nonsmoker status, and age between 20 and 35 years. Six subjects failed to meet the inclusion criteria and were therefore excluded. The remaining 200 subjects underwent a neuropsychological test battery. An EDTA-anticoagulated blood sample (10 ml) was drawn from each subject for genotype analysis.
The primary intention of the cognitive test battery was to investigate the individual's prefrontal executive function, including sustained/divided attention, set-shifting capability, working memory, and psychomotor speed. This was based on previous investigations that successfully correlated the in vivo parameters of dopamine synthesis capacity with individual cognitive performance results . We used the Stroop test , the Trail Making Test part B (TMT-B) , and a degraded-stimulus version of the continuous performance task (dsCPT) in combination with signal detection theory (adapted from Kathmann et al. ). When performing the latter test, 360 pictures were presented on a 21-inch screen. A total of 180 of these pictures showed a well-perceptible cross (‘+'), and 180 pictures showed the digits ‘0'-‘9'. The picture representing the ‘0' was defined as the target digit. Half of the 180 digits had well-perceptible contours, whereas the other half of the digits were presented with markedly blurred contours. Each digit was followed by a cross. The sequence of digits was randomly assigned with respect to the choice of digit (‘0'-‘9') and their perceptibility (blurred vs. clear). After every presentation, an interstimulus interval of 1 s was interposed. The subject was instructed to press a button (independently from the sharpness) as fast as possible every time the digit ‘0' or a cross (‘+') was presented. The pictures were shown in blocks of 120 (60 digits and 60 crosses) presentations with 15-second breaks; the complete test took 12 min. The main outcome parameter was the percentage of correctly identified blurred ‘0' digits. Crosses and nonblurred ‘0' digits were included only for the validation of the subject's compliance.
The dsCPT was analyzed according to the signal detection theory . Therefore, the parameters for hits, missed false alarms, and correct rejections were entered into the analysis using the BayesSDT software package for Matlab .
We additionally examined the personality traits of the subjects with the German version of the NEO Five-Factor Inventory (FFI)  and the short version of the Temperament and Character Inventory (TCI) .
Genomic DNA was isolated from peripheral lymphocytes with a routine salting-out procedure. For the determination of the AP-2β and MAOA genotypes, standard polymerase chain reaction (PCR) amplifications were performed in a 25-µl volume containing 80 ng of genomic DNA, 1 unit of recombinant Taq polymerase (Invitrogen, Germany), PCR buffer (10 mM Tris-HCl, 50 mM KCl, 2.5 mM MgCl2, pH 8.3), 200 mM dNTPs, and 20 pmol of each primer. The AP-2β primer sequences were obtained from Damberg et al. , and the MAOA primers were obtained from Sabol et al. . For both variants, the forward primers were carboxyfluorescein-labeled. The PCR was run on an MJ PTC200 Temperature Cycler (Biozym, Germany), and each of the 35 cycles consisted of a 95°C denaturation step for 45 s, a 63°C (AP-2β)/62°C (MAOA) annealing step for 30 s, and, finally, a 72°C elongation step for 90 s. PCR products were run on an automated sequencing system (AB3130, Applied Biosystems, USA), and the electropherograms were analyzed with gene mapping software (Applied Biosystems, USA).
The COMT Val158Met genotypes were determined with a pyrosequencing assay. The region of interest was amplified using the same standard PCR conditions as those described above. Primer sequences were the following: COMT_Pyro_F (5′-CCCAGCGGATGGTGGATTT-3′) and COMT_Pyro_S (5′-GCGGATGGTGGATTT-3′). The PCR amplification was performed as described for the AP-2β analysis, except the annealing temperature was 57°C. After amplification, single strands were prepared with the Vacuum Prep Tool (Biotage, Uppsala, Sweden), which was followed by a denaturation step at 85°C for 2 min and the final sequencing primer hybridization (primer: COMT_Pyro_R: biotin-5′-CCTTTTTCCAGGTCTGACAACG-3′). Pyrosequencing was conducted with the PyroMark Gold Q96 reagents kit (Biotage AB).
Based on the results of Damberg et al. , we genetically defined the following 3 subgroups according to the individual [CAAA] repeat status of AP-2β: the homozygote 4/4-repeat allele combination (short alleles), the heterozygote 4/5-repeat allele group, and the homozygote 5/5-repeat allele carriers (long allele). Additionally, the subjects were subdivided into high-, medium-, or low-activity groups for the VNTR MAOA polymorphism and the COMT polymorphism. For the VNTR MAOA genotype, 3/3-repeat homozygotes were designated as low-activity, 3/3.5 or 3/4 heterozygotes were designated as medium-activity, and genotypes with 2 copies of the 3.5- or 4-repeat alleles were designated as high-activity subjects. The COMT Val158Met allele combination Met/Met was designated as low activity, the Val/Met combination was designated as medium, and the Val/Val allele combination was designated as high activity.
In order to investigate the main effects of the 3 genotypes (AP-2β, COMT, and MAOA) on cognition and personality, one-way ANOVAs were performed on the mean differences between the high-, medium-, and low-activity groups. In cases exhibiting significant results, a Sidak post hoc analysis was performed. In order to correct for multiple testing with respect to the number of cognitive tasks (dsCPT, TMT-B, Stroop), a Bonferroni correction was also performed: p values less than 0.016 were considered to be statistically significant.
In order to analyze the interactions of the 3 polymorphisms, a generalized linear model was applied for all of the main outcome variables for the Stroop, dsCPT hits, decision bias (β), and TMT-B tests. The model included the 3 genetic main effects as predictors, age as a covariate, and the 2 gene × gene interaction terms.
The Hardy-Weinberg equilibrium was analyzed with a web tool by Rodriguez et al. .
The allele frequencies for the variable number of AP-2β [CAAA] sequences were 38.5% (n = 154) for 4 × [CAAA] and 61.3% (n = 245) for 5 × [CAAA], and there was 1 rare variation (0.3%). The VNTR MAOA polymorphism allele frequencies were 3-repeat [31.8% (n = 127)], 3.5-repeat [1.8% (n = 7)], 4-repeat [65.3% (n = 261)], and 5-repeat [1.3% (n = 5)]. The allele frequencies for the COMT Val158Met genotypes were 43% (n = 172) for the Val allele and 57% (n = 228) for the Met allele. See table 1 for the group frequencies of the polymorphisms or genetic groups, respectively. All polymorphisms were in Hardy-Weinberg equilibrium (AP-2β: χ2 = 3, p > 0.05; MAOA: χ2 = 0.34, p > 0.05; COMT: χ2 = 0.34, p > 0.05). No significant differences were found for age or educational level in the 3 genetic groups.
The one-way ANOVA for the AP-2β polymorphism revealed a significant main effect on the TMT-B results (F = 4.831, d.f. = 2, p = 0.009, n = 199; table 2). The Sidak post hoc analyses revealed that the 4/4 (40.33 ± 9.01) carriers performed better than the 5/5 carriers (49.77 ± 11.29; p = 0.007) and the 4/5 carriers (47.62 ± 14.39; p = 0.038) (for details, see table 3 and fig. 1). The other cognitive tests did not show any significant group differences. The group difference between 4/4 and 5/5 carriers survived Bonferroni correction for the inclusion of multiple cognitive tasks.
The MAOA and COMT polymorphisms exhibited no significant effects on the performances of the cognitive tasks in the present sample.
The COMT polymorphism showed main effects on some dimensions of the NEO-FFI and TCI. The openness item in the NEO-FFI revealed a main group effect (F = 3.575, d.f. = 2, p = 0.030, n = 198). The corresponding post hoc analysis indicated that the Val/Val group showed significantly higher scores when compared to the Val/Met group (p = 0.036) (for results, see table 4) but not when compared to the Met/Met group. Within the TCI, the self-transcendence subscale was significantly influenced by COMT (F = 3.329, d.f. = 2, p = 0.038, n = 170). Further analysis showed that the Met/Met group had significantly lower scores than the Val/Val group (27.45 ± 12.79 vs. 35.68 ± 16.54, p = 0.033) (table 5).
No significant effects on personality were found for the AP-2β and MAOA polymorphisms.
Furthermore, a negative correlation between decision bias β and neuroticism of the NEO-FFI exists (r = -1.46, p = 0.04); there were no significant correlations between β and any further personality items.
In order to investigate the possible interactions between the genes, the main effects of the AP-2β, MAOA, and COMT genotypes, as well as the interaction terms AP-2β × MAOA, AP-2β × COMT, and AP-2β × MAOA × COMT, with age as a scaled covariate, were tested in a generalized linear model. Highly significant main effects were found for all 3 polymorphisms: AP-2β, MAOA, and COMT (χ2 = 7.466, p = 0.024; χ2 = 11.675, p = 0.003; χ2 = 9.111, p = 0.011, respectively). Furthermore, there were interaction effects of AP-2β and MAOA and for AP-2β, MAOA, and COMT (χ2 = 12.044, p = 0.017; χ2 = 25.923, p = 0.004, respectively; table 6). Post hoc t tests for the AP-2β × MAOA interaction showed that, in the high-activity MAOA group, a significant difference in decision bias existed between the 4/4 AP-2β carriers and the 4/5 carriers (t = 2.431, p = 0.018) (fig. 2). The 4/4 carriers showed a more conservative bias, whereas the 4/5 carriers showed only a minimally conservative bias. Due to the genetic distribution and allele frequencies, some genetic interaction clusters consisted of less than 2 subjects (see fig. 3 for AP-2β × MAOA interaction). No reasonable interpretations can be drawn from these clusters. Nevertheless, these findings with respect to the decision bias encourage performing replication studies with larger sample.
The post hoc analyses for the AP-2β × MAOA × COMT interaction revealed that there was a significant difference in the decision bias between the MAOA high-activity group (MAOA-H) × COMT (Val/Met) × 5/5 AP-2β and the MAOA low-activity group (MAOA-L) × COMT (Val/Met) × 5/5 AP-2β, which showed that the MAOA-L group had a liberal bias, whereas the MAOA-H group showed a more conservative bias. Further post hoc tests exhibited a significant difference for the MAOA-H × COMT (Val/Met) group between the 4/5 AP-2β and 5/5 AP-2β carriers (t = -2.717, p = 0.01), resulting in a more conservative bias for group 5/5. The difference between the 4/5 and 5/5 carriers in the MAOA-L × COMT (Val/Met) group showed an even stronger significance (t = 8.636, p = 0.003). The 5/5 carriers showed a liberal bias, whereas the 4/5 carriers had a conservative bias. The MAOA-L × COMT (Val/Met) × 5/5 AP-2β group had a significantly more liberal bias than almost every other combination with the 5/5 Ap-2β allele (see fig. 4 for AP-2β × MAOA × COMT interaction).
Besides these effects on the decision bias, a borderline-significant interaction between AP-2β, MAOA, and COMT for the hit rate of the dsCPT was shown (χ2 = 18.025, d.f. = 10; p = 0.055).
There were no effects for the TMT-B or the Stroop interference task. After very conservative correction for multiple testing, including all test modalities, assessments, and genotypes, no significant group differences could be observed.
In the present study, we investigated the effects of the polymorphisms of AP-2β, MAOA, and COMT on the cognitive performance and personality dimensions of a sample of 200 healthy female subjects. The choices of the polymorphisms and the study protocol were strictly hypothesis-driven by the postulated tight functional interplay of their corresponding gene products on the metabolism of catecholamines.
The main finding was a positive group effect of the AP-2β genotype on the TMT-B, which is a task that previously showed robust associations with dopaminergic in vivo parameters . The corresponding post hoc analysis indicated that those individuals with 2 short alleles performed better on the TMT-B than the heterozygote and homozygote long-allele subjects. Interestingly, the group effects of the MAOA promoter polymorphism, as well as the rs4680 COMT polymorphism, showed far less pronounced and nonstatistically significant associations with cognitive performance, even though several (but not all) previous investigations reported a reliable influence of these genotypes on catecholaminergic metabolism [12,13,25]. Nevertheless, Damberg et al.  observed that females who are homozygotic for the short allele showed lower HVA levels than subjects with at least 1 long allele. Thus, the AP-2β genotype appears to be functionally relevant to dopamine metabolism, potentially by modulating the transcription of the MAOA gene. Indeed, most of the previous investigations have reported a positive association of HVA concentrations and cognitive outcome parameters. This has mainly been interpreted to be caused by variations in dopamine synthesis. An AP-2β-associated reduction of MAOA  and COMT transcription might reduce dopamine metabolism, resulting in lower dopamine turnover rates and increased dopamine availability because less dopamine is degraded into HVA. In general, most healthy subjects would benefit from high dopaminergic capacities . The results of the Stroop task were similar but failed to reach statistical significance. However, due to our COMT and MAOA results, it is critical to explain the AP-2β effects through the possible modulation of the transcription of a single metabolic enzyme.
The VNTR MAOA polymorphism is functionally able to interfere with dopamine metabolism. Furthermore, it has previously been described to affect intelligence, aggression, risk taking, antisocial behavior, and treatment response [26,27,28,29]. In our sample, there were no significant effects on the cognitive performance parameters; however, we found a trend-like relationship. Interestingly, this relationship was counterintuitive: high-activity allele carriers showed slightly better cognitive results in the TMT-B and the Stroop task. Earlier studies have indicated that high-activity allele carriers should have lower dopamine levels and higher dopamine turnover. Nevertheless, our results were consistent with a previous report in healthy subjects that showed that MAOA-H carriers have a higher IQ compared with MAOA-L carriers .
Finally, we did not find any effects of COMT on executive functioning. There are some inconsistencies among previous investigations as to whether the COMT Val158Met polymorphism has a significant impact on individual cognitive performance. A meta-analysis by Barnett et al.  that included 46 studies concluded that the COMT polymorphism has only a small influence, if any, on cognitive performance. Our findings supported these results. It might be that the COMT polymorphism does not explain a significant proportion of individual performances while subjects are executing tasks that demand attention, set shifting, and working memory abilities. The absent or counterintuitive results in the present sample for the COMT Val158Met and VNTR MAOA polymorphisms do not support the idea that the AP-2β polymorphism exerts its effect on cognition simply through COMT and MAOA modulation, as previously thought. The direct effects of AP-2β on cognitive performance in the absence of any effects of COMT/MAOA suggest that the physiological mechanisms that are involved in the AP-2β association are not entirely based on the rate of dopamine metabolism but may also depend on the modulation of the transcription of various other gene products that are involved in signal transduction in the central nervous system.
The generalized linear model analysis, however, elucidated that decision bias (β), in particular, was highly affected by multiple genotypes. All 3 polymorphisms showed significant main effects. Furthermore, the interaction of AP-2β, MAOA, and COMT (χ2 = 32.826, p < 0.005) showed a strong impact. These data suggested that the functional interplay between the corresponding gene products modulated the subject's decision making through dopamine metabolism. The decision bias provided a measure of whether decisions were generally more conservative or liberal. A score of 0 meant that there was no response bias, a positive score indicated a bias towards saying ‘no', whereas a negative score indicated a bias towards saying ‘yes' [20,30]. Looking at the results, simple interpretations of the high- or low-activity genotypes were not applicable as low MAOA subjects tended to show no bias and low COMT activity subjects showed a more conservative bias. Including the AP-2β promoter polymorphism in the statistical model provided a necessary factor for the interpretation of the model results. The MAOA-L/COMT (Val/Met)/AP-2β 5/5 carriers showed a more liberal bias compared to all other MAOA/COMT/AP-2β 5/5 groups. Because none of the 3 polymorphisms showed a liberal bias, it may be concluded that the interaction of the 3 genes turned the conservative or neutral biases into a more liberal one. These results need to be interpreted with caution due to the fact that some gene combinations had a very small group size (n < 2). Since some gene/allele frequencies are comparatively low, the presence of rare gene combinations is consequential. In fact, the actual group sizes (gene combinations) do not relevantly differ from the calculated and expected sizes. It may be speculated that the transcription rates of the AP-2β polymorphism had the most prominent effect in the group with the highest dopamine availability (MAOA-L/COMT-Val/Met). A study by Vernaleken et al.  supports this interpretation. In that positron emission tomography study, subjects with high baseline D2/3 receptor availability initially show better cognitive performance. However, when the dopamine system is challenged with ketamine, they show the highest level of drug-induced impairments. Thus, one might speculate that a subject with high levels of dopamine might be more vulnerable to manipulations of the structures, metabolism, or environmental stress. Nevertheless, it is more likely that these interactions involve complex neurobiological interactions of diverse structures rather than depict unidirectional and circumscribed mechanisms of the hierarchical pathway (i.e., transcription factor → MAOA/COMT transcription → MAOA/COMT activity → dopaminergic availability).
However, there is a negative correlation between neuroticism and decision bias β. Higher neuroticism is associated with less conservative bias/greater liberal bias. The decision bias β is a value of the individual's weighing how to make the right decision. Subjects with more liberal bias tend to rather interpret a degraded stimulus as correct hit than to take the chance of omission. Subjects with more conservative bias, on the other hand, want to be rather sure that a degraded stimulus is unambiguously a correct target. The present correlational findings are in line with the literature: Burton et al.  found that neuroticism is negatively correlated with the decision bias β. Furthermore, they also found that in females the bias is negatively correlated with openness: higher scores of openness are associated with more liberal decisions. This association between these complex measures of personalities (mainly reflecting aspects of impulsivity) with distinct outcome parameters of a circumscribed cognitive task is astonishing but intuitive in its direction.
The current investigation also described a possible relationship between AP-2β/MAOA/COMT polymorphisms and personality factors. Based on the known literature, it is hypothesized that some subscales of personality questionnaires are associated with the dopamine system. Especially, novelty seeking and extraversion are suggested to be affected by dopamine transmission [33,34,35,36]. These results, however, highly depend on the choice of assessment tools. In this sample, carriers of the Val/Val allele of the COMT polymorphism showed significantly lower scores on the self-transcendence subscale in the character part of the TCI compared to Met/Met and Val/Met carriers. Comings et al.  found that this subscale is sensitive to some genes that are involved in the dopaminergic system, including COMT. Similarly, in our sample, the Val/Val group scored higher on the NEO-FFI subscale of openness to experience, which has also been hypothesized to be associated with the dopaminergic system . However, additional results of Deyoung et al.  present the opposite results of COMT and openness with Met/Met carriers having higher scores of openness compared to the Val/Val group. Our results showed only a marginal difference between the 2 groups, even though this was a significant result. However, the previous study tested children who were aged between 8 and 13 years, who were non- or maltreated, and who grew up under low-income conditions . In the present study, healthy female subjects (mainly students) were included, and this might suggest a bias of environmental or developmental factors. However, no socioeconomic data were systematically collected. Further investigations are needed to clarify this. Contrary to our expectation, there was no relationship between extraversion, novelty seeking, and the genotypes. This might be due to several reasons. As mentioned before, questionnaires differ in their ability to delineate personality traits complying with underlying neurobiological mechanisms. It is possible that the present choice of questionnaires which represents our standard protocol is not optimal to depict dopamine-related personality traits. Furthermore, it remains unclear whether the strict exclusion of male subjects impacts the results. Otherwise, there are previous studies which were also unable to find associations between the dopamine system (or AP-2β) and novelty seeking [36,40].
In the present population, there were no effects of AP-2β on personality. Alternatively, a previous study of Damberg et al.  indicated that AP-2β influences anxiety-related traits. Several reasons may account for this discrepancy. The sample sizes were comparatively low in both studies, and differences in inclusion criteria might be a relevant factor. Finally, Damberg et al.  used the Karolinska Scales of Personality, whereas, in this investigation, the NEO-FFI and the TCI were used. Another study of Damberg et al.  that used the TCI and the NEO-PI-R did not detect any associations either. A relevant impact of the AP-2β genotype on personality traits thus remains in question.
In summary, the AP-2β genotype is an important modulating factor of structures related to dopaminergic transmission. The data indicated that AP-2β had more influence on cognition than MAOA and COMT. Because MAOA and COMT showed little effect on cognition, we propose that AP-2β might influence cognition through pathways other than those that regulate MAOA and COMT.
This work was supported by the German Research Foundation (DFG, VE 466/2-1, the IZKF Aachen, and IRTG 1328, International Research Training Group). Special thanks to Christine Frank.
Dr. Steven J. Siegel has received grant support from Astellas and AstraZeneca and has been a consultant to NuPathe, Lundbeck and Abbott regarding material that is unrelated to the work in the manuscript. Dr. Gerhard Gründer has served as a consultant for Bristol-Myers Squibb (New York, N.Y., USA), Cheplapharm (Greifswald, Germany), Eli Lilly (Indianapolis, Ind., USA), Lundbeck (Copenhagen, Denmark), Otsuka (Rockville, Md., USA), and Servier (Paris, France). He has served on the speaker's bureau of Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, Janssen Cilag, Otsuka, Pfizer, and Servier. He has received grant support from Alkermes, Bristol-Myers Squibb, Eli-Lilly, and Johnson & Johnson. He is co-founder of Pharma-Image - Molecular Imaging Technologies GmbH (Germany). Dr. Klaus Zerres, Dr. Thomas Eggermann, Dr. Ingo Vernaleken, and Ina Schabram do not have any conflicts of interest to declare.
Department of Psychiatry, Psychotherapy, and Psychosomatics
RWTH Aachen University
Pauwelsstrasse 30, DE-52074 Aachen (Germany)
Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.